British Columbia Investment Management Corp Abbott Laboratories Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

A detailed history of British Columbia Investment Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, British Columbia Investment Management Corp holds 290,263 shares of ABT stock, worth $33.6 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

290,263

Previous 332,348 12.66%

Holding current value

$33.6 Million

Previous $34.5 Million 4.18%

% of portfolio

0.21%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $4.21 Million - $4.97 Million	-42,085 Reduced 12.66%	290,263 $33.1 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $12.5 Million - $14 Million	124,378 Added 59.81%	332,348 $34.5 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $898,283 - $992,113	8,202 Added 4.11%	207,970 $23.6 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $3.76 Million - $4.6 Million	41,644 Added 26.34%	199,768 $22 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $100,497 - $120,580	1,052 Added 0.67%	158,124 $15.3 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $117,106 - $130,480	1,162 Added 0.75%	157,072 $17.1 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $48,720 - $57,347	503 Added 0.32%	155,910 $15.8 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $1.72 Million - $2.02 Million	-18,112 Reduced 10.44%	155,407 $17.1 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $3.03 Million - $3.51 Million	-31,362 Reduced 15.31%	173,519 $16.8 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $6.97 Million - $8.42 Million	-68,273 Reduced 24.99%	204,881 $22.3 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $4.4 Million - $5.37 Million	-38,610 Reduced 12.38%	273,154 $32.3 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $1.95 Million - $2.38 Million	-16,836 Reduced 5.12%	311,764 $43.9 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $104,294 - $115,379	894 Added 0.27%	328,600 $38.8 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $3.89 Million - $4.58 Million	36,771 Added 12.64%	327,706 $38 Million
Q1 2021 Apr 30, 2021	SELL	$108.84 - $128.23 $953,656 - $1.12 Million	-8,762 Reduced 2.92%	290,935 $34.9 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $792,435 - $863,527	-7,547 Reduced 2.46%	299,697 $32.8 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $2.24 Million - $2.72 Million	24,470 Added 8.65%	307,244 $33.4 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $6.85 Million - $8.76 Million	89,396 Added 46.23%	282,774 $25.9 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $14.1 Million - $20.5 Million	-223,682 Reduced 53.63%	193,378 $15.3 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $1.04 Million - $1.16 Million	13,299 Added 3.29%	417,060 $36.2 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $3.2 Million - $3.47 Million	-39,091 Reduced 8.83%	403,761 $33.8 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $856,267 - $998,665	11,749 Added 2.73%	442,852 $37.2 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $6.95 Million - $8.4 Million	-104,947 Reduced 19.58%	431,103 $34.5 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $234,049 - $265,143	3,570 Added 0.67%	536,050 $38.8 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $7.69 Million - $9.28 Million	-126,468 Reduced 19.19%	532,480 $39.1 Million
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $1.32 Million - $1.46 Million	-22,912 Reduced 3.36%	658,948 $40.2 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $4.62 Million - $5.22 Million	-82,119 Reduced 10.75%	681,860 $40.9 Million
Q4 2017 Feb 20, 2018	BUY	$53.68 - $57.47 $2.44 Million - $2.61 Million	45,420 Added 6.32%	763,979 $43.6 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $34.5 Million - $38.5 Million	718,559	718,559 $38.3 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Abbott Laboratories Transaction History